McKesson Corp. closed 6.87% below its 52-week high of $637.51, which the company reached on August 2nd.

Shares of McKesson Corp. MCK shed 2.52% to $595.00 Wednesday, on what proved to be an all-around poor trading session for the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

IRVING, Texas, January 30, 2025--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on April 1, 2025, to ...

'The trajectory for most of our long-term initiatives is going to be a lot clearer by the end of this year,' said CEO Mark Zuckerberg.

McKesson (MCK) Company Description: Incorporated in 1833, Texas-based McKesson Corp. provides pharmaceuticals, health information technology, medical supplies, and care management tools.

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against Larry Robbins’ other long-term stock picks. Larry Robbins is an American hedge fund manager ...

McKesson Corp provides medicines, pharmaceutical supplies, information and care management products and services across the healthcare industry. It operates with two segments namely McKesson ...